Join the Oncology Voice Network. Join for Free
The Art of Story Telling for Impactul Engagement
storytelling in medical affairs engaging Key Opinion Leaders effective storytelling techniques building relationships with KOLs impactful communication in MSLs

The Art of Story Telling for Impactul Engagement


Share This Article


Summary

In this episode, Angela Valadez joins Tom Caravela to explore the power of storytelling in medical affairs. Angela shares her journey and emphasizes the critical role storytelling plays in engaging Key Opinion Leaders (KOLs). She discusses the benefits and key elements of effective storytelling, offering practical techniques for MSLs during KOL meetings. Angela shares personal experiences and best practices, highlighting storytelling as a means to build relationships and facilitate two-way dialogues. The conversation also touches on using storytelling to request referrals and combining it with data for impactful communication. The episode concludes with actionable tips and resources for MSLs.

Angela Valadez, Senior Manager Field Medical Affairs at Regeneron shares insights on how to use story telling to ensure more impactful engagement.

Click for Source
storytelling in medical affairs, engaging Key Opinion Leaders, effective storytelling techniques, building relationships with KOLs, impactful communication in MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Article
Where Did My Interview Go Wrong?
Partner Avatar Tom Caravela

Where Did My Interview Go Wrong?

Article
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
OVN Avatar Nidal Al-Huniti, Yan Feng, Jingyu (Jerry) Yu, Zheng Lu, Mario Nagase, Diansong Zhou, Jennifer Sheng

Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities

Explore OVN